Increased detection of 14-3-3 protein in cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease during the disease course

European Neurology

Volumn 48, Issue 4, 2002, Pages 218-221

  Giraud, Pierric ^a,b   Biacabe, Anne Gaëlle ^b,d   Chazot, Guy ^b   Later, Roger ^b   Joyeux, Olivier ^c   Moene, Yves ^a   Perret Liaudet, Armand ^b  

^a Centre Hospitalier de la Region d'Annecy   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c CENTRE HOSPITALIER DE VALENCE   (France)

^d Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Creutzfeldt Jakob; CSF protein; EEG; Protein 14 3 3

Indexed keywords

PROTEIN 14 3 3; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; IATROGENIC DISEASE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN SECRETION; TIME PERCEPTION; MIDDLE AGED; PROGNOSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TIME; WESTERN BLOTTING;

14-3-3 PROTEINS; AGED; BLOTTING, WESTERN; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 0036045222     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066174     Document Type: Article

References (11)

1. Zerr I, Pocchiari M, Collins S, Brandel JP, De Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Lauprètre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremon A, Budka H, Laplanche JL, Will RG, Poser S: Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-815.
2. Masters C, Richardson EP: Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 1978;101:333-344.
3. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichenberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H: Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-233.
4. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-930.
5. Beaudry P, Cohen P, Brandel JP, Delasnerie-Lauprètre N, Richard S, Launey JM, Laplanche JL: 14-3-3 protein, neuron-specific enolase and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 1999;10:40-46.
6. Brandel JP, Beaudry P, Delasnerie-Lauprètre N, Laplanche JL: Maladie de Creutzfeldt-Jakob: Valeur diagnostique de la détection de la protéine 14-3-3 et du dosage de la NSE dans le liquide céphalorachidien. Rev Neurol (Paris) 1999;2:148-151.
7. Brandel JP, Peoc'H K, Beaudry P, Welartne A, Bottos C, Agid Y, Laplanche JL: 14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients. Ann Neurol 2001;49:257-260.
8. Chapman T, Mc Keel DJ, Morric JC: Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:1396-1397.
9. Kropp S, Zerr I, Schulz-Schaeffer WJ, Riedmann C, Bodemer M, Laske C, Kretzschmar HA, Poser S: Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease. Neurosci Lett 1999;261:124-126.
10. Jimi T, Wakayama Y, Shibuya S, Nakata H, Tomaru T, Takahashi Y, Kosaka K, Asano T, Kato K: High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage of Creutzfeldt-Jakob disease. Clin Chim Acta 1992;211:37-46.
11. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T: Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40.